SCHEMBL24079207

SCHEMBL24079207

CC(C)SCN1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.44
CHRM3 P20309 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SIGMAR1 Q99720 3/20 0.33
CXCR4 P61073 2/20 0.33
LMNA P02545 1/20 0.32
PHGDH O43175 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 1/20 0.31
RECQL P46063 1/20 0.31
ANPEP P15144 1/20 0.31
ERAP2 Q6P179 1/20 0.31
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
RAD52 P43351 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21082263 0.79 CHRM5 (0.43) CHRM5CHRM3SMN1; SMN2POLBHSD17B10
SCHEMBL1385192 0.78 MEN1 (0.39) CHRM5CHRM3SIGMAR1LMNAMEN1
SCHEMBL21235725 0.77 SMN1; SMN2 (0.54) CHRM5CHRM3SMN1; SMN2POLBLMNA
SCHEMBL18735945 0.74 MGLL (0.38) POLBSIGMAR1LMNAPHGDHALDH1A1
SCHEMBL20459374 0.73
SCHEMBL872595 0.73 USP2 (0.46) SMN1; SMN2HSD17B10LMNAPHGDHALDH1A1
SCHEMBL15224399 0.72 SMN1; SMN2 (0.41) CHRM5CHRM3SMN1; SMN2POLBHSD17B10
SCHEMBL154268 0.70 SMN1; SMN2 (0.56) CHRM5CHRM3SMN1; SMN2POLBHSD17B10
SCHEMBL10667505 0.70 SMN1; SMN2 (0.56) CHRM5CHRM3SMN1; SMN2POLBHSD17B10
SCHEMBL1393824 0.70 SMN1; SMN2 (0.56) CHRM5CHRM3SMN1; SMN2POLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11191769-B2 Fused thiophene compounds BIOTHERYX, INC. (US) 2021-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11191769-B2 Fused thiophene compounds SSB, ICAM1, VCAM1 CHRM5 4458/4885CHRM3 4310/4885SMN1; SMN2 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.